Motherisk Update: Tumour necrosis factor alpha and use of infliximab. Safety during pregnancy

Alan Shrim, Gideon Koren

نتاج البحث: نشر في مجلةمقالةمراجعة النظراء

7 اقتباسات (Scopus)

ملخص

Question: A 27-year-old patient of mine with rheumatoid arthritis has been treated with infliximab for the last 5 years. She is planning her first pregnancy. How should I advise her regarding use of infliximab during pregnancy, bearing in mind that infliximab substantially improved her medical condition? Answer: Infliximab (Remicade) has not been tested in pregnant animals because it does not interact with non-human tumour necrosis factor (TNF) alpha. Several case reports describing women who used infliximab during pregnancy do not suggest a strong association with adverse pregnancy outcomes. More studies are required to determine infliximab's safety during pregnancy.

اللغة الأصليةالإنجليزيّة
الصفحات (من إلى)667-668
عدد الصفحات2
دوريةCanadian Family Physician
مستوى الصوت51
رقم الإصدارMAY
حالة النشرنُشِر - مايو 2005
منشور خارجيًانعم

بصمة

أدرس بدقة موضوعات البحث “Motherisk Update: Tumour necrosis factor alpha and use of infliximab. Safety during pregnancy'. فهما يشكلان معًا بصمة فريدة.

قم بذكر هذا